AGA Family of Websites: Gastro.org
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
GutsGraphic
February 11, 2020

What patients need to know about IBD treatments

Help your patients understand aminosalicylates, corticosteroids, biosimilars and more to better manage their condition.
Share on facebook
Share on twitter
Share on linkedin
Share on email

Share the AGA Patient Education Section in the February 2020 issue of Clinical Gastroenterology and Hepatology (CGH) to help your patients with inflammatory bowel disease (IBD) understand their medical treatment options, including:

  • Aminosalicylates.
  • Corticosteroids.
  • Immunosuppressants.
  • Biologics.
  • Biosimilars.

This is part of a series of articles that is being published bimonthly in the AGA Patient Education Section of CGH on what patients need to know about living with IBD. The series can be found in its entirety in the AGA GI Patient Center, along with more specific information about potential side effects and examples of each class of drugs.

The “What patients need to know about living with IBD” series was reviewed by Deborah D. Proctor, MD, AGAF, and David T. Rubin, MD, AGAF.

Content creation was funded through an educational grant from Takeda Pharmaceuticals U.S.A., Inc. Takeda had no control over the editorial content.

Brought to you by the
AGA Center for Gut Microbiome Research & Education
Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.